Genpact Limited director Carol J. Lindstrom filed a Form 144 notice of proposed sale of securities with the SEC on November 9, 2026, disclosing plans to sell 2,364 shares of Genpact common stock through Morgan Stanley Smith Barney LLC.

Key Highlights

  • Seller: Carol J. Lindstrom, identified in the filing as a Director of Genpact Limited.
  • Shares proposed for sale: 2,364 shares of Genpact common stock, with an aggregate market value of $100,611.84, according to the filing.
  • Approximate date of sale: November 9, 2026, to be executed on the NYSE.
  • Source of shares: The shares were acquired on December 31, 2024, as restricted stock from the issuer, with payment listed as "Not Applicable."
  • Shares outstanding: The filing reports 167,226,996 shares of Genpact common stock outstanding.
  • Prior sales: The filing reports nothing to report under securities sold during the past 3 months.

Lindstrom Restricted Stock Award Background and Proposed Sale Details

According to the Form 144 notice, Genpact Limited (NYSE:G) director Carol J. Lindstrom intends to sell 2,364 shares of the company's common stock. The proposed sale is to be conducted through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, with the approximate sale date listed as November 9, 2026, on the NYSE.

The filing discloses that the shares were acquired on December 31, 2024, via a restricted stock transaction from the issuer, Genpact Limited. The nature of payment is listed as "Not Applicable," and no gift status is indicated. The aggregate market value of the 2,364 shares proposed for sale is stated as $100,611.84 in the filing. Genpact's SEC file number is listed as 001-33626, and the company's address is Canon's Court, 22 Victoria Street, Hamilton, Bermuda HM 12.

The filing notes no securities were sold by Lindstrom during the past three months. By signing the notice, the filer represented, as stated in the form, that she "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." No written trading plan date under Rule 10b5-1 is indicated in the filing.

What Was Disclosed

Genpact director Carol J. Lindstrom filed a Form 144 on November 9, 2026, proposing to sell 2,364 common shares with an aggregate market value of $100,611.84, acquired as restricted stock on December 31, 2024, with no prior sales in the past three months.